Brigham Walker

Brigham Walker

Auto-generated profile, based on publicly available information

Brigham Walker

Tulane University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2023 in Medical Care
Verified
Journal Article
Open access
BWBrigham Walker
Brigham Walker
CSCharles Stoecker
Charles Stoecker
YSYixue Shao
Yixue Shao
ENElizabeth Nauman
Elizabeth Nauman
DFDaniel Fort
Daniel Fort
LSLizheng Shi
Lizheng Shi
Background: At the onset of the COVID-19 pandemic, the Centers for Medicare and Medicaid Services broadened access to telehealth. This provided an opportunity to test whether diabetes, a risk factor for COVID-19 severity, can be managed with telehealth services. Objective: The objective of this study was to examine the impacts of telehealth on diabetes control. Research Design: A doubly robust estimator combined a propensity score–weighting strategy with regression controls for baseline characteristics using electronic medical records data to compare outcomes in patients with and without telehealth care. Matching on preperiod trajectories in outpatient visits and weighting by odds were used to ensure comparability between comparators. Subjects: Medicare patients with type 2 diabetes in Louisiana between March 2018 and February 2021 (9530 patients with a COVID-19 era telehealth visit and 20,666 patients without one). Measures: Primary outcomes were glycemic levels and control [ie, hemoglobin A1c (HbA1c) under 7%]. Secondary outcomes included alternative HbA1c measures, emergency department visits, and inpatient admissions. Results: Telehealth was associated with lower pandemic era mean A1c values [estimate=−0.080%, 95% confidence interval (CI): −0.111% to −0.048%], which translated to an increased likelihood of having HbA1c in control (estimate=0.013; 95% CI: 0.002–0.024; P<0.023). Hispanic telehealth users had relatively higher COVID-19 era HbA1c levels (estimate=0.125; 95% CI: 0.044–0.205; P<0.003). Telehealth was not associated with differences in the likelihood of having an emergency department visits (estimate=−0.003; 95% CI: −0.011 to 0.004; P<0.351) but was associated with more the likelihood of having an inpatient admission (estimate=0.024; 95% CI: 0.018–0.031; P<0.001). Conclusion: Telehealth use among Medicare patients with type 2 diabetes in Louisiana stemming from the COVID-19 pandemic was associated with relatively improved glycemic control.

24 December 2021 in Vaccine
Verified
Journal Article
Open access
BWBrigham Walker
Brigham Walker
AAAndrew Anderson
Andrew Anderson
CSCharles Stoecker
Charles Stoecker
YSYixue Shao
Yixue Shao
TLThomas A. LaVeist
Thomas A. LaVeist
KCKevin Callison
Kevin Callison
The COVID-19 pandemic disrupted routine vaccinations for children and adolescents. However, it remains unclear whether the impact has been different for children and adolescents from low-income families. To address this, we compared monthly routine vaccination use per 1000 vaccine-eligible children and adolescents enrolled in Louisiana Medicaid in the years before (2017–2019) and during the COVID-19 pandemic (2020). Compared to the 2017–2019 average vaccination rates, we found a 28% reduction in measles, mumps, and rubella (MMR), a 35% reduction in human papillomavirus (HPV), and a 30% reduction in tetanus, diphtheria, pertussis (Tdap) vaccinations in 2020. Vaccine uptake was lower in April 2020 after the declaration of a state of emergency and in late summer when back-to-school vaccinations ordinarily occur. We found little evidence of recovery in later months. Our findings suggest that a substantial number of disadvantaged children may experience longer periods of vulnerability to preventable infections because of missed vaccinations.

1 August 2021 in American Journal of Public Health
Verified
Journal Article
Closed access
KCKevin Callison
Kevin Callison
BWBrigham Walker
Brigham Walker
Objectives. To identify the association between Medicaid eligibility expansion and medical debt. Methods. We used difference-in-differences design to compare changes in medical debt for those gaining coverage through Louisiana’s Medicaid expansion with those in nonexpansion states. We matched individuals gaining Medicaid coverage because of Louisiana’s Medicaid expansion (n = 196 556) to credit report data on medical debt and compared them with randomly selected credit reports of those living in Southern nonexpansion state zip codes with high rates of uninsurance (n = 973 674). The study spanned July 2014 through July 2019. Results. One year after Louisiana Medicaid expansion, medical collections briefly rose before declining by 8.1 percentage points (95% confidence interval [CI] = –0.107, –0.055; P ≤ .001), or 13.5%, by the third postexpansion year. Balances also briefly rose before falling by 0.621 log points (95% CI = –0.817, –0.426; P ≤ .001), or 46.3%. Conclusions. Louisiana’s Medicaid expansion was associated with a reduction in the medical debt load for those gaining coverage. These results suggest that future Medicaid eligibility expansions may be associated with similar improvements in the financial well-being of enrollees.

2 December 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
ETEthan Tsai
Ethan Tsai
BWBrigham Walker
Brigham Walker
SWShiao-Chi Wu
Shiao-Chi Wu
Objective This study evaluates the effectiveness of Taiwan’s nationwide oral cancer screening programme in reducing late-stage diagnosis, treatment delays and mortality. Design A retrospective cohort study was conducted. Setting The study utilized Nationally representative datasets, including the Cancer Registry, Oral Mucosal Screening and National Health Insurance databases in Taiwan. Participants The study included patients with oral cancer diagnosed between 1 January 2010 and 31 December 2013, with follow-up through 31 December 2018. The final analysis included 16 430 patients. Intervention The intervention was Taiwan’s nationwide oral cancer screening programme which provides visual inspection and palpation of the oral mucosa. Primary outcome measures The primary outcomes measured were late-stage diagnosis (stages III and IV), treatment delay (time from diagnosis to treatment >30 days) and all-cause mortality. Results Oral cancer screening was statistically significantly associated with a reduced likelihood of late-stage diagnosis (adjusted OR (AOR)=0.85, 95% CI 0.80 to 0.91, p<0.01). However, screening was also associated with a higher likelihood of treatment delay (AOR=1.09, 95% CI 1.00 to 1.19, p=0.049). Taken together, the screening programme is associated with a slightly lower hazard of death (adjusted HR=0.94, 95% CI 0.89 to 0.99, p=0.01). Conclusion While Taiwan’s nationwide oral cancer screening programme effectively reduced late-stage diagnoses and mortality, barriers to timely treatment access remain. Ensuring prompt diagnosis and treatment following screening may further enhance the survival benefits of the programme.

17 January 2023 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
DVDovile Vilda
Dovile Vilda
BWBrigham C. Walker
Brigham C. Walker
RHRachel R. Hardeman
Rachel R. Hardeman
MWMaeve E. Wallace
Maeve E. Wallace

1 March 2021 in Economics Letters
Verified
Journal Article
Closed access
JWJanna Wisniewski
Janna Wisniewski
BWBrigham Walker
Brigham Walker
STSarah Tinkler
Sarah Tinkler
MSMiron Stano
Miron Stano
RSRajiv Sharma
Rajiv Sharma